Previous studies have shown that DEPTOR levels are reduced in metastatic cancer cells (e.g., endometrial cancer tissues and breast cancer cells), and DEPTOR reduction or depletion promotes EMT (epithelial–mesenchymal transition), whereas its overexpression represses this process [22]. Here, DEPTOR is linked to breast carcinoma.